Skip to main content
Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om os
  • Nyheder
  • Instrument service
  • Antimicrobial resistance
  • Messer og udstillinger
  • Aidian Academy
  • Kunde historier
Kontakt os Søg
Logo
Kontakt os
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Point of care
  • QuikRead go-systemet
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • ACRO™ Biotech
  • Hangzhou AllTest Biotech
Læs mere
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Uricult Vet
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Molekylær mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
  • Aidian i Danmark
  • Bestyrelse og direktion
  • Bæredygtighed
  • Kultur
  • Karriere
  • Nyheder
  • Produktnyheder
  • AMR
  • Begivenheder
  • Stories from customers
  • COVID-19
  • Om C-reaktivt protein (CRP)
  • CRP and lower respiratory tract infections
  • Understøttende materialer
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Documents and materials
  • Frequently asked questions
  • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Logo
Kontakt os Tæt
  • Produkter
    • Point of care
      • QuikRead go-systemet
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • ACRO™ Biotech
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Uricult Vet
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Molekylær mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • Luftvejsinfektioner
    • Andre
      • Grifols Promonitor®
  • Om os
    • Aidian i Danmark
    • Bestyrelse og direktion
    • Bæredygtighed
    • Kultur
    • Karriere
  • Nyheder
    • Nyheder
    • Produktnyheder
    • AMR
    • Begivenheder
    • Stories from customers
    • COVID-19
  • Instrument service
  • Antimicrobial resistance
    • Om C-reaktivt protein (CRP)
    • CRP and lower respiratory tract infections
    • Understøttende materialer
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Messer og udstillinger
  • Aidian Academy
    • Generally
    • Product information
    • Documents and materials
    • Frequently asked questions
  • Kunde historier
    • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Populære produkter
AllTest hCG hurtig test

AllTest hCG hurtig test

AllTest MONO hurtig test

AllTest MONO hurtig test

Acro Strep A hurtig test

Acro Strep A hurtig test

Seneste nyt
Se alt

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Increase in influenza and RSV activity in the EU/EEA

14. januar 2025 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...
Nyheder

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Tilbage til alle nyheder
29. november 2023
Nyheder,
Produktnyheder

Benefits of Bladder EpiCheck for bladder cancer surveillance

As November, Bladder Health Month 2023, is coming to an end we want to highlight Bladder Cancer surveillance.

Bladder cancer is the 5th most common cancer in Europe, affecting over 200 000 people yearly.1 Non-muscle-invasive bladder cancer (NMIBC) accounts for the majority of newly diagnosed bladder cancers. With up to 70% of patients experiencing recurrence within 2 years of initial treatment and 10-15% progressing to higher risk cancer, monitoring of bladder cancer is vital.2

The current gold standard methods for bladder cancer surveillance are cystoscopy and cytology. However, they have their limitations as both are based on operator-dependent assessment. Cytology has low to moderate sensitivity, while some types of tumours are easily missed in cystoscopy.2

During the first years after initial treatment, bladder cancer patients undergo as many as 4 cystoscopies a year. Cystoscopy is an invasive and expensive procedure, so the need for an effective biomarker test for surveillance is high.

Bladder EpiCheck® from Nucleix is a urine marker test for monitoring of NMIBC. It uses a panel of 15 DNA methylation markers and is included in the EAU (European Association of Urology) guidelines for bladder cancer surveillance. The guidelines state that Bladder EpiCheck could be used to replace and/or postpone cystoscopy.3

Bladder EpiCheck

A meta-analysis of the diagnostic accuracy of urinary biomarker tests found that Bladder EpiCheck has a high-grade Negative Predictive Value (NPV) of 99 %, high-grade sensitivity of 91 % and specificity of 84 %.4

The results of the test are objective and not affected by BCG treatment, hematuria, or infections.5 The high performance of the test makes it a reliable tool to rule out high-risk recurrence and reduce unnecessary procedures.

Reducing the number of cystoscopies by incorporating Bladder EpiCheck into the surveillance of bladder cancer could lessen the strain on the healthcare system as well as benefit the well-being of patients.

For more detailed information about Bladder EpiCheck, head to the Bladder EpiCheck product site or contact us.

Aidian is the proud distributor of Bladder EpiCheck in the Nordics.


References

  1. European Association of Urology. Bladder Cancer: The Forgotten Cancer. https://uroweb.org/news/bladder-cancer-the-forgotten-cancer. Accessed 27.11.2023.
  2. Biomarkers in the management of non-muscle invasive bladder cancer (NMIBC), BCaMonitor, Updated May 2023.
  3. EAU Non-muscle-invasive Bladder Cancer guidelines 2022. https://uroweb.org/guidelines/non-muscle-invasive-bladder-cancer/chapter/diagnosis
  4. Laukhtina et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol 2021 Dec;4(6):927-942; and corrigendum at Eur Urol Oncol. 2022 Jan 19;S2588-9311(22)00004-9.
  5. Cochetti et al. Urol Onc Nov 2021; Pierconti et al. Urol Onc Nov 2021, Bladder EpiCheck® EU Instructions For Use, 09-May-2022


Share
Facebook
Twitter
E-mail

Aidian Denmark ApS

Ørestads Boulevard 73,
2300 København S


+45 8610 3020


Forespørgsler
info@aidian.dk


Salg
order@aidian.dk

Selskab
  • Om os
  • Bæredygtighed
  • Karriere
  • Kontakt os
Produkter
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Hurtige links
  • Aidian Academy
Copyright © 2025 Aidian
  • Persondatapolitik
  • Erklæring om beskyttelse af persondata
  • Cookie-politik
  • Sociale medier politik